GlassScriptPhysician profile
Ryan Anthony Tonucci
NPI 1437551488
$5,557.28
in general payments reported to CMS, 2019-2025
26 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,725 · 2022: $1,186 · 2023: $1,591 · 2024: $893 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,289 · Travel and Lodging: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,288.92 |
| Travel and Lodging | $357.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Liberty Surgical INC. | $1,200.00 | 2021 | |
| Stryker Corporation | $917.71 | 2021-2025 | 7 X 23mm Citrelock Implant, Citrefix, Variax |
| Kerecis Limited | $800.36 | 2022-2024 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Paragon 28, INC. | $493.54 | 2024 | Additive Orthopedics, Phantom Hindfoot |
| Bioventus LLC | $417.58 | 2021-2023 | Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $288.96 | 2021-2025 | Grafix Xc, Stravix, Stravix Pl |
| Aroa Biosurgery Incorporated | $191.58 | 2022 | |
| Nevro Corp. | $168.85 | 2023 | Senza |
| Convatec INC. | $158.12 | 2022-2023 | |
| Paratek Pharmaceuticals, INC. | $136.47 | 2021-2022 | |
| Ossio INC | $125.55 | 2023 | |
| Alexion Pharmaceuticals, INC. | $125.03 | 2022 | |
| Kci USA, INC. | $87.85 | 2022 | |
| Treace Medical Concepts, INC. | $73.00 | 2025 | |
| Depuy Synthes Sales INC. | $65.22 | 2022-2023 | Axert |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $49.18 | 2023-2024 | Tirosint, Licart, Tirosint |
| Musculoskeletal Transplant Foundation INC. | $45.29 | 2023 | |
| Abbvie INC. | $38.01 | 2023 | Dalvance |
| Hartmann USA, INC. | $34.24 | 2022-2025 | Zetuvit Plus 10x10 P10 |
| Bone Support INC. | $29.07 | 2022 | |
| Averitas Pharma INC. | $24.65 | 2023 | Qutenza |
| Accufix Surgical INC. | $22.23 | 2022 | |
| Tactile Systems Technology INC | $18.53 | 2025 | Nimbl, Flexitouch Plus |
| Synergy Orthopedics, LLC | $17.32 | 2023 | |
| Metric Medical Devices, INC. | $16.66 | 2023 | Super Staple, Super Scaffold |
| Heron Therapeutics, INC. | $12.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Tonucci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.